SIBIONICS und PharmaSens erkunden auf der EASD 2026 neue Horizonte für die automatisierte Insulinabgabe

ConferenceNeutral

AI Analysis

Summary

SiBionics and PharmaSens presented an automated insulin delivery solution integrating continuous glucose monitoring at the EASD 2026 conference in Milan, emphasizing early intervention capabilities for diabetes care.

Importance:3/10

Sentiment:

0.20

automated insulin deliverycontinuous glucose monitoringdiabetes managementEASD 2026partnership

Read the original article

Published by PR Newswire Pharma on October 5, 2026 2:54 AM

Read Original